Candida auris Surveillance, Molecular Detection, PCR, Varies
Use
Detecting Candida auris from surveillance swabs. This test facilitates the identification of Candida auris, a pathogen known to cause serious infections and is often drug-resistant, from surveillance swabs. Routine screening is recommended for patients with recent hospitalizations outside of the US and healthcare workers in close contact with infected patients, enhancing infection control and prevention of disease transmission in healthcare settings.
Special Instructions
Not provided.
Limitations
A negative result does not rule out the presence of Candida auris due to potential levels below the assay's detection limit. This test detects nucleic acid, not distinguishing viable organisms from residual nucleic acid from prior infections. Results should be correlated with clinical presentation. It should not be used to determine cure or monitor response to therapy.
New York Approved
Methodology
PCR-based (Real-Time PCR)
Biomarkers
Candida auris
Microorganism
LOINC Codes
- 95765-4 - C auris DNA Spec Ql NAA+n-prb
- 31208-2 - Specimen source
- 95765-4 - C auris DNA Spec Ql NAA+n-prb
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Other
Volume
Swab
Minimum Volume
Not provided
Container
ESwabs in liquid Amies medium
Collection Instructions
Swab used for this test cannot be shared with fungal culture. Use separate swabs if both tests are ordered. Transport containers must have a pledget saturated with Stuart's or Amies liquid media.
Storage Instructions
Specimen must arrive within 7 days of collection.
Causes for Rejection
Wood shaft or charcoal swab; Culturette swab; Clear semi-solid/solid media
Stability Requirements
| Temperature | Period |
|---|---|
| Refrigerated | 7 days |
| Frozen | 7 days |